Spirometry is a good method for detecting and monitoring chronic obstructive pulmonary disease in high-risk smokers in primary health care;La espirometría es un buen método para la detección y el seguimiento de la EPOC en fumadores de alto riesgo en atención primaria

Archivos de Bronconeumologia

Volumn 40, Issue 4, 2004, Pages 155-159

  Clotet, J ^a,b   Gomez Arbones X ^b   Ciria, C ^a   Albalad, J M ^a  

^a Centro de Atencion Primaria de Ponts   (Spain)

^b UNIVERSITY OF LLEIDA   (Spain)

Author keywords

Chronic obstructive pulmonary disease; High risk group; Spirometry; Susceptible smokers

Indexed keywords

ADULT; AGED; ARTICLE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL FEATURE; CLINICAL OBSERVATION; DISEASE PREDISPOSITION; EARLY DIAGNOSIS; FEMALE; FORCED EXPIRATORY VOLUME; HIGH RISK PATIENT; HUMAN; MAJOR CLINICAL STUDY; MALE; PRACTICE GUIDELINE; PRIMARY HEALTH CARE; PROSPECTIVE STUDY; SCREENING; SMOKING; SMOKING CESSATION; SPIROMETRY; TOBACCO;

EID: 2442668950     PISSN: 03002896     EISSN: None     Source Type: Journal    
DOI: 10.1157/13058850     Document Type: Article

References (10)

1. Montemayor T, Alfajeme I, Escudero C, Morera J, Sánchez Agudo L. Grupo de trabajo de la SEPAR. Normativa sobre diagnóstico y tratamiento de la enfermedad pulmonar obstructiva crónica. Arch Bronconeumol 1996;32:285-301.
2. Sobradillo V, Miravitlles M, Jiménez CA, Gabriel R, Viejo JL, Masa JF, et al. Estudio IBERPOC en España: prevalencia de síntomas respiratorios habituales y de limitación crónica al flujo aéreo. Arch Bronconeumol 1999;35:159-66.
3. Anthonisen NR, Connett JE, Kiley JP, Altose MD, Bailey WC, Buist AS, et al. Effects of smoking intervention and the use of an inhaled anticholinergic bronchodilatador on the rate of decline of FEV1. The Lung Health Study. JAMA 1994;272:1497-505.
4. Miravitlles M, Fernández I, Guerrero T, Murio C. Desarrollo y resultados de un programa de cribado de la EPOC en atención primaria. El proyecto PADOC. Arch Bronconeumol 2000;36:500-5.
5. Van Schayck CP, Loozen JMC, Wagena E, Akkermans RP, Wesseling GJ. Detecting patients at a high risk of developing chronic obstructive pulmonary disease in general practice: cross sectional case finding study. BMJ 2002;324:1370-3.
6. Zieliñski J, Bednarek M. Early detection of COPD in a high-risk population using spirometric screening. Chest 2001;119:731-6.
7. Sanchis J y Grupo de trabajo de la SEPAR. Normativa para la práctica de la espirometría forzada. Arch Bronconeumol 1989;25:132-42.
8. Siafakas NM, Vermeire P, Pride NB, Paoletti P, Gibson J, Howard P, et al. Optimal assessment and management of chronic obstructive pulmonary disease (COPD). Eur Respir J 1995;8:1398-420.
9. Hankinson JL, Wagner GR. Medical screening using periodic spirometry for detection of chronic lung disease. Occup Med 1993;8:353-61.
10. Enright PL, Crapo RO. Controversies in the use of spirometry for early recognition and diagnosis of chronic obstructive pulmonary disease in cigarette smokers. Clin Chest Med 2000;21:645-52.